HYDERABAD, India (Kyodo) Dr. Reddy's Laboratories Ltd., India's second-largest pharmaceutical company, is considering setting up an office in Tokyo or Osaka next year in an effort to break into the Japanese generic drug market, CEO G.V. Prasad said in a recent interview.
"Japan remains the focus area for us," said Prasad, who doubles as the company's vice chairman, at his office in Hyderabad.
Dr. Reddy's is an aggressive firm, and in February it chalked up India's biggest-ever purchase of an overseas firm.